A 3-hour time interval may not be sufficient for delayed enhancement magnetic resonance imaging with intravenous gadoteridol injection based on 3d-real IR sequence of the inner ear in Meniere’s disease patient

References

• Hallpike CS, Cairns H. Observations on the pathology of Meniere’s syndrome: (section of otology). Proc R Soc Med. 1938;31(11):1317–1336. https://pubmed.ncbi.nlm.nih.gov/19991672/ doi: 10.1177/003591573803101112.
   PubMedGoogle Scholar
• Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117(3):415–420. doi: 10.1097/MLG.0b013e31802c300c.
   PubMed Web of Science ®Google Scholar
• Naganawa S, Komada T, Fukatsu H, et al. Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol. 2006;16(3):733–737. doi: 10.1007/s00330-005-0046-8.
   PubMed Web of Science ®Google Scholar
• Sano R, Teranishi M, Yamazaki M, et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol. 2012;132(3):241–246. doi: 10.3109/00016489.2011.639085.
   PubMed Web of Science ®Google Scholar
• Naganawa S, Suzuki K, Yamazaki M, et al. Serial scans in healthy volunteers following intravenous administration of gadoteridol: time course of contrast enhancement in various cranial fluid spaces. Magn Reson Med Sci. 2014;13(1):7–13. doi: 10.2463/mrms.2013-0056.
   PubMed Web of Science ®Google Scholar
• Barlet J, Vaussy A, Ejzenberg Y, et al. Optimized 3D-FLAIR sequences to shorten the delay between intravenous administration of gadolinium and MRI acquisition in patients with Meniere’s disease. Eur Radiol. 2022;32(10):6900–6909. doi: 10.1007/s00330-022-08889-y.
   PubMed Web of Science ®Google Scholar
• Chen W, Geng Y, Lin N, et al. Magnetic resonance imaging with intravenous gadoteridol injection based on 3D-real IR sequence of the inner ear in Meniere’s disease patient: feasibility in 3.5-h time interval. Acta Otolaryngol. 2021;141(10):899–906. doi: 10.1080/00016489.2021.1973681.
   PubMed Web of Science ®Google Scholar
• Goebel JA. 2015 Equilibrium committee amendment to the 1995 AAO-HNS guidelines for the definition of Meniere’s disease. Otolaryngol Head Neck Surg. 2016;154(3):403–404. doi: 10.1177/0194599816628524.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Naganawa S, Pyykko I, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl. 2009;560(560):5–8. doi: 10.1080/00016480902729827.
   Google Scholar
• Naganawa S, Suzuki K, Yamazaki M, et al. Time course for measuring endolymphatic size in healthy volunteers following intravenous administration of gadoteridol. Magn Reson Med Sci. 2014;13(2):73–80. doi: 10.2463/mrms.2013-0080.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Teranishi M, Naganawa S, et al. Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. Acta Otolaryngol. 2011;131(2):130–135. doi: 10.3109/00016489.2010.507781.
   PubMed Web of Science ®Google Scholar
• Tagaya M, Yamazaki M, Teranishi M, et al. Endolymphatic hydrops and blood-labyrinth barrier in meniere’s disease. Acta Otolaryngol. 2011;131(5):474–479. doi: 10.3109/00016489.2010.534114.
   PubMed Web of Science ®Google Scholar
• Li X, Wu Q, Sha Y, et al. Gadolinium-enhanced MRI reveals dynamic development of endolymphatic hydrops in meniere’s disease. Braz J Otorhinolaryngol. 2020;86(2):165–173. doi: 10.1016/j.bjorl.2018.10.014.
   PubMed Web of Science ®Google Scholar
• Grieve S, Obholzer R, Malitz N, et al. Imaging of endolymphatic hydrops in Meniere’s disease at 1.5 T using phase-sensitive inversion recovery: (1) demonstration of feasibility and (2) overcoming the limitations of variable gadolinium absorption. Eur J Radiol. 2012;81(2):331–338. doi: 10.1016/j.ejrad.2011.01.073.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Sugimoto S, Teranishi M, et al. Imaging of the endolymphatic space in patients with Meniere’s disease. Auris Nasus Larynx. 2018;45(1):33–38. doi: 10.1016/j.anl.2017.02.002.
   PubMed Web of Science ®Google Scholar
• Pyykkö I, Nakashima T, Yoshida T, et al. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013;3(2):e001555. doi: 10.1136/bmjopen-2012-001555.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jia H, Shi J, et al. Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Meniere’s disease. Med Sci Monit. 2015;21:701–707. doi: 10.12659/msm.892383.
   PubMed Web of Science ®Google Scholar
• Wu Q, Dai C, Zhao M, et al. The correlation between symptoms of definite Meniere’s disease and endolymphatic hydrops visualized by magnetic resonance imaging. Laryngoscope. 2016;126(4):974–979. doi: 10.1002/lary.25576.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Yoshida T, Sugiura S, et al. Endolymphatic hydrops in patients with unilateral and bilateral meniere’s disease. Acta Otolaryngol. 2017;137(1):23–28. doi: 10.1080/00016489.2016.1217042.
   PubMed Web of Science ®Google Scholar